Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.phrs.2019.104272

QiShenYiQi Pills® ameliorates ischemia/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGFβ1/Smads signaling pathway

..., Jing-Yan Han
7
Pharmacological Research9.30
Volume: 146, Pages: 104272 - 104272
Published: Aug 1, 2019
Abstract
QiShenYiQi Pills (QSYQ) is a compound Chinese medicine widely used in China for treatment of cardiovascular disease. However, limited data are available regarding the anti-fibrotic role of QSYQ after ischemia/reperfusion (I/R) injury. This study aimed to investigate the effect of post-treatment with QSYQ on myocardial fibrosis after I/R-induced myocardium injury, and the role of different compounds of QSYQ, focusing especially on the involvement...
Paper Fields
Paper Details
Title
QiShenYiQi Pills® ameliorates ischemia/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGFβ1/Smads signaling pathway
DOI
doi.org/10.1016/j.phrs.2019.104272
Published Date
Aug 1, 2019
Journal
Pharmacological Research
Volume
146
Pages
104272 - 104272
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.